Ovalis
Stage
Series B | AliveTotal Raised
$6.6MLast Raised
$6.6M | 16 yrs agoAbout Ovalis
Ovalis was formed by several highly experienced device engineers to develop a set of interventional devices and delivery systems useful for the repair of various cardiovascular defects.
Missing: Ovalis's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Ovalis's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Ovalis Patents
Ovalis has filed 6 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/16/2012 | 6/10/2014 | Congenital heart defects, Embryology of cardiovascular system, Rare diseases, Diving medicine, Bones of the head and neck | Grant |
Application Date | 11/16/2012 |
---|---|
Grant Date | 6/10/2014 |
Title | |
Related Topics | Congenital heart defects, Embryology of cardiovascular system, Rare diseases, Diving medicine, Bones of the head and neck |
Status | Grant |
Ovalis Frequently Asked Questions (FAQ)
Where is Ovalis's headquarters?
Ovalis's headquarters is located at 1920 Old Middlefield Way, Mountain View.
What is Ovalis's latest funding round?
Ovalis's latest funding round is Series B.
How much did Ovalis raise?
Ovalis raised a total of $6.6M.
Who are the investors of Ovalis?
Investors of Ovalis include De Novo Ventures, Latterell Venture Partners and Abbott.
Who are Ovalis's competitors?
Competitors of Ovalis include CeQur, Cardiva Medical, Paragon Medical, Activaero, Monterey Devices and 11 more.
Compare Ovalis to Competitors
PPI was formed from the merger of three companies (MPI International, Skill Tool & Die, and Precision Gear) to manufacture complex, high-precision metal components for the automotive, defense, medical device and construction industries.
Vascure is a medical device company. The company is developing an therapeutic device for percutaneous treatment of arterial disease. Vascure's system will offer a one-stop solution for restoring blood flow to narrowed or occluded blood vessels in a range of clinical conditions, including heavily calcified lesions. Vascure will provide Intervantionalists with a safe and easy to use device, shortening procedure time, allowing percutaneous treatment in cases previously requiring radical surgical procedures and generating improved clinical outcomes.

CeQur is developing and commercializing advanced yet simple-to-use insulin delivery devices that make it easier for people living with type 2 diabetes to adhere to therapy and stay in control of their disease. The Company's fully optimized device, PaQ, is a three-day, wearable device that provides freedom from multiple daily insulin injections.
ThermalTherapeutic Systems is currently developing a portable next-generation perfusion device for international distribution.
Medtronic Biomedicus, Inc, Sterile Systems Operation has been providing EtO Sterilization services since 1990. Sterile Systems has four large chambers and a single smaller one. Because the company have chambers of multiple sizes, the company can easily handle loads from one cart to eight pallets. Sterile Systems is owned by Medtronic, a publicly traded medical device manufacturers. The company are able to leverage the benefits of being part of a multi-national corporation, but still offer the kind of customer service and personalized attention users get from design to sterilized product.
The company's goal is to develop medical devices to improve care for people with serious diseases. The current focus aims to provide medical researchers with an effective, flexible means to develop treatments and diagnosis through the use of microbubbles. Microbubbles are a proven medical product used to enhance ultrasound imaging. Researchers and physicians are beginning to demonstrate the enormous potential of ultrasound and microbubble enhanced therapies " please see resources for a list of publications. Artenga's medical device is annon-demand system to generate microbubbles optimized for therapy.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.